News in English

GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision

GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision fkansteiner

Читайте на сайте